Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 83.21-18.9040.1821.22112.25

What is the latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS is 83.21 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202583.21
Mar2024-18.90
Mar202340.18
Mar202221.22
Mar2021112.25

How is Core EBITDA Growth of JAGSONPAL PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 83.21
Positive
Mar2024 -18.9
Negative
Mar2023 40.18
89.35
Mar2022 21.22
-81.10
Mar2021 112.25 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,565.4 Cr 3.4% 18.2% 9.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,704.0 Cr -0.5% 3.9% 12.1% Stock Analytics
DIVIS LABORATORIES ₹173,684.0 Cr -3.1% -0.1% 0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,093.0 Cr 3.1% 6.7% 45.5% Stock Analytics
CIPLA ₹117,699.0 Cr 1.4% 4.8% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹111,792.0 Cr 0.8% 3.9% 1.5% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

3.4%

18.2%

9.3%

SENSEX

1%

2.9%

-6.1%


You may also like the below Video Courses